Trial Profile
REgistry of MisOprostol 200 µg Vaginal dElivery System (REMOVE)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Sep 2015
Price :
$35
*
At a glance
- Drugs Misoprostol (Primary)
- Indications Labour induction
- Focus Therapeutic Use
- Acronyms REMOVE
- Sponsors Ferring Pharmaceuticals
- 15 Sep 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Aug 2015 Planned End Date changed from 1 Jul 2015 to 1 Sep 2015, as reported by ClinicalTrials.gov.
- 17 Aug 2015 Planned primary completion date changed from 1 Jul 2015 to 1 Aug 2015, as reported by ClinicalTrials.gov.